EcoDrugPlus

Opioid Receptor, Delta 1b

Ensembl ID : ENSTNIG00000014036
Gene Symbol: OPRD1B
3 Cross references
121 Possible Orthologues:

Opioid Receptor, Kappa 1

Ensembl ID : ENSTNIG00000018641
Gene Symbol: OPRK1
3 Cross references
197 Possible Orthologues:

Opioid Receptor, Mu 1

Ensembl ID : ENSTNIG00000017009
Gene Symbol: OPRM1
3 Cross references
214 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSTNIG00000014737
Gene Symbol: OXTR
3 Cross references
183 Possible Orthologues:

Oxytocin Receptor A

Ensembl ID : ENSTNIG00000014624
Gene Symbol: OXTRA
3 Cross references
191 Possible Orthologues:

P21 Protein (Cdc42/rac)-Activated Kinase 4

Ensembl ID : ENSTNIG00000006800
Gene Symbol: PAK4
2 Cross references
166 Possible Orthologues:

Parathyroid Hormone 1 Receptor

Ensembl ID : ENSTNIG00000008477
Gene Symbol: PTH1R
2 Cross references
196 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSTNIG00000014805
Gene Symbol: PPARG
3 Cross references
386 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha A

Ensembl ID : ENSTNIG00000009618
Gene Symbol: PPARAA
2 Cross references
383 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha B

Ensembl ID : ENSTNIG00000006254
Gene Symbol: PPARAB
2 Cross references
396 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Delta B

Ensembl ID : ENSTNIG00000015112
Gene Symbol: PPARDB
2 Cross references
392 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha

Ensembl ID : ENSTNIG00000006780
Gene Symbol: PIK3CA
2 Cross references
181 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).